Assistance Publique - Hôpitaux de Paris: Myelodysplastic Syndromes trials
The registry lists 11 Myelodysplastic Syndromes studies with Assistance Publique - Hôpitaux de Paris as lead sponsor. 4 are open to participants now and 0 have results posted.
Phase 2 4Phase 3 2No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Peri-graft Cytokine Profile: Influence of Hematologic Disease and Donor TypeNot yet recruitingNCT07805746
- Upfront Related Donor Transplantation in Patients With Myelodisplatic Syndrome : a Phase 2 TrialNot yet recruitingNCT06235398Phase 2
- Clonal Hematopoiesis of Immunological SignificanceNot yet recruitingNCT05969821
- The Patient Cohort of the National Center for Precision Medicine in LeukemiaRecruitingNCT05326919
- Calprotectin, a Biomarker of COVID-19 Severity (CALPRO)WithdrawnNCT04953312Not applicable
- Evaluation of a Donor Testing Kit for the Prediction of AGVHD in Patient Receiving a Peripheral Blood Stem Cell AllograftStatus unknownNCT03887156Phase 2/3
- HLA 10/10 Matched Unrelated Donor vs Haploidentical Allogenic Hematopoietic Stem Cell TransplantationStatus unknownNCT03655145Phase 3
- Myelodysplasic Syndromes and Risk Factors for InfectionStatus unknownNCT02905552
- Prospective Study of Molecular Predictors of Survival in Myelodysplastic SyndromesCompletedNCT02619565Not applicable
- Best Promising Drug Association With Azacitidine in Higher Risk Myelodysplastic SyndromesStatus unknownNCT01342692Phase 2
- 5-azacytidine Valproic Acid and ATRA in AML and High Risk MDSCompletedNCT00339196Phase 2